BETHESDA, Md. & ABBOTT PARK, Ill.--(BUSINESS WIRE)-- Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) and Abbott (NYSE:ABT) today announced positive top-line data from a 48-week phase 3 long-term safety ...
A medication used to treat constipation, lubiprostone, may protect the kidneys and slow down damage caused by gut bacteria.
Morning Overview on MSN
A common constipation drug may have accidentally unlocked a new way to slow chronic kidney disease
Lubiprostone has been on pharmacy shelves for nearly two decades, prescribed to help people with stubborn constipation. Nobody designed it to protect kidneys. But a randomized clinical trial published ...
Review the side-effects of Lubiprostone as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...
Lubiprostone preserved renal function in stage IIIb-IV CKD patients over 24 weeks without altering uremic toxin levels, suggesting a novel renoprotective mechanism. The trial demonstrated ...
Learn everything you need to know about Lubiprostone-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, ...
BETHESDA, Md. & ABBOTT PARK, Ill.--(BUSINESS WIRE)-- Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) and Abbott (NYSE:ABT) today announced that a pivotal phase 3 clinical trial of lubiprostone for ...
A phase 2 trial suggests that a drug commonly used for constipation may help preserve kidney function in people with moderate to severe chronic kidney disease by reshaping the gut microbiome and ...
Esophagus stomach Lubiprostone was significantly more effective in improving abdominal pain or bloating than placebo, according to results from a post-hoc analysis published in Alimentary Pharmacology ...
September 26, 2012 (Phoenix, Arizona) — Constipation drug lubiprostone (Amitiza, Sucampo Pharmaceuticals, Takeda Pharmaceuticals) shows efficacy and tolerability in treating opioid-induced ...
A 16-µg dose of lubiprostone, a medication used in the management of constipation, improved or preserved estimated glomerular filtration rate (eGFR) in patients with chronic kidney disease (CKD), ...
BETHESDA, Md. & ABBOTT PARK, Ill.--(BUSINESS WIRE)-- Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) and Abbott (NYSE:ABT) today announced positive top-line data from a 48-week phase 3 long-term safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results